Pharmacokinetic-pharmacodynamic assessment of the safety of fexinidazole for the treatment of human African trypanosomiasis

Similar Items

• Pharmacokinetic-pharmacodynamic assessment of the hepatic and bone-marrow toxicities of the new trypanoside fexinidazole
  by: Watson, J, et al.
  Published: (2019)
• Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole
  by: Philippe Neau, et al.
  Published: (2020-01-01)
• Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
  by: Sonja Bernhard, et al.
  Published: (2022-10-01)
• Fexinidazole and Human African Trypanosomiasis: good news for this important neglected tropical disease
  by: Taciana de Souza Bayão, et al.
• The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis.
  by: Eric Pelfrene, et al.
  Published: (2019-06-01)